The long range objectives of the proposed research are to characterize the nature and the extent of interaction between the terminal complement proteins (C5, C6, C7, C8, C9), which together form the membrane attack complex (MAC) of complement, and lipids and proteins in artificial and natural target membranes. We want to understand the mechanism of assembly of this complex on a cell's surface and elucidate the mechanisms through which the MAC can either cause immune cytolysis and cell death or protect host cells from auto- destruction. We expect to attain our long range goals by using a combination of biophysical, biochemical and immunochemical techniques to investigate the assembly of the MAC and its effect on the target membrane. Our studies will focus predominantly on C9 because this protein provides the main lytic and cytotoxic functions of the MAC. We will use the synthetic peptide approach to generate an epitope map of native C9 and of C9 when bound to target membrane. Circular dichroism and electron spin resonance (ESR) spectroscopy will be used to analyze conformational changes in the protein as they assemble on and penetrate into the membrane. The corresponding changes in lipid bilayer structure will be monitored by ESR and differential scanning calorimetry. The resulting MAC-membrane complex will visualized by freeze- fracture electron microscopy. Localization of the active center of C9 will be attempted by producing proteolytic fragments with lytic or cytotoxic activity. Such activities will be assayed by measuring release of markers from liposomes, or changes in conductance across planar lipid bilayers, and by testing peptides directly for their effects on survival of blood cells and bacteria.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI019478-06
Application #
3128818
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
1982-04-01
Project End
1992-03-31
Budget Start
1987-04-01
Budget End
1988-03-31
Support Year
6
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Florida
Department
Type
Schools of Veterinary Medicine
DUNS #
073130411
City
Gainesville
State
FL
Country
United States
Zip Code
32611
Wang, Y; Bjes, E S; Esser, A F (2000) Molecular aspects of complement-mediated bacterial killing. Periplasmic conversion of C9 from a protoxin to a toxin. J Biol Chem 275:4687-92
Thielens, N M; Enrie, K; Lacroix, M et al. (1999) The N-terminal CUB-epidermal growth factor module pair of human complement protease C1r binds Ca2+ with high affinity and mediates Ca2+-dependent interaction with C1s. J Biol Chem 274:9149-59
Rossi, V; Bally, I; Thielens, N M et al. (1998) Baculovirus-mediated expression of truncated modular fragments from the catalytic region of human complement serine protease C1s. Evidence for the involvement of both complement control protein modules in the recognition of the C4 protein substrate. J Biol Chem 273:1232-9
Esser, A F; Tarnuzzer, R W; Tomlinson, S et al. (1996) Horse complement protein C9: primary structure and cytotoxic activity. Mol Immunol 33:725-33
Tomlinson, S; Wang, Y; Ueda, E et al. (1995) Chimeric horse/human recombinant C9 proteins identify the amino acid sequence in horse C9 responsible for restriction of hemolysis. J Immunol 155:436-44
Esser, A F (1994) The membrane attack complex of complement. Assembly, structure and cytotoxic activity. Toxicology 87:229-47
Esser, A F; Thielens, N M; Zaccai, G (1993) Small angle neutron scattering studies of C8 and C9 and their interactions in solution. Biophys J 64:743-8
Tomlinson, S; Ueda, E; Maruniak, J E et al. (1993) The expression of hemolytically active human complement protein C9 in mammalian, insect, and yeast cells. Protein Expr Purif 4:141-8
Tomlinson, S; Stanley, K K; Esser, A F (1993) Domain structure, functional activity, and polymerization of trout complement protein C9. Dev Comp Immunol 17:67-76
Tomlinson, S; Esser, A F (1992) Rapid immunological screening for protein expression in yeast transformants. Biotechniques 13:710-1

Showing the most recent 10 out of 27 publications